Enteromedics

Enteromedics company information, Employees & Contact Information

Explore related pages

Related company profiles:

ReShape Lifesciences™ is the weight loss company that offers products and solutions to help people with obesity throughout the treatment continuum. Our current portfolio includes surgical & non-surgical weight loss treatments, such as the Lap-Band® Program, the ReShape Vest™ & the ReShapeCare™ Program. The company is rapidly advancing its innovative technologies to broadly benefit patients, healthcare providers & stakeholders worldwide. The Lap-Band helps patients take control over their weight, because only the Lap-Band can be tightened or loosened as their body or physical needs change, helping provide sustainable weight loss over the long term. The Lap-Band is the only FDA approved laparoscopic weight loss procedure commercially available in the U.S. & covered by most insurance companies. It gives patients control over their body too, because it’s the safest weight loss surgery available, with the lowest complication & mortality rate, because it does not cut out the majority of the stomach or reroute intestines. ReShape Lifesciences is committed to advancing the future of weight loss procedures as evidenced by the ReShape Vest. An investigational, minimally invasive, laparoscopically implanted medical device that wraps around the stomach, emulating the gastric volume reduction effect of conventional weight-loss surgery & is intended to enable rapid weight loss in obese & morbidly obese patients without permanently changing patient anatomy. Currently, the ReShape Vest is in European clinical trials & not commercially available for sale. ReShapeCare™ is a reimbursable, customizable, virtual weight management program that focuses on helping surgical & non-surgical patients treat, manage, & improve the chronic, metabolic disease of obesity, directed by their physician. This evidence-based program increases access to & coordination of care from certified health coaches. Patients can conveniently get the personalized help they need.
Looking for a particular Enteromedics employee's phone or email?

Enteromedics Questions

News

ReShape Lifesciences® Announces Partial Adjournment of Special Meeting of Stockholders - GlobeNewswire

ReShape Lifesciences® Announces Partial Adjournment of Special Meeting of Stockholders GlobeNewswire

ReShape Lifesciences® Announces EU MDR Certification for Entire European and United Kingdom Product Portfolio - GlobeNewswire

ReShape Lifesciences® Announces EU MDR Certification for Entire European and United Kingdom Product Portfolio GlobeNewswire

EnteroMedics Announces FDA Approval of VBLOC® Vagal Blocking Therapy for the Treatment of Obesity - MultiVu

EnteroMedics Announces FDA Approval of VBLOC® Vagal Blocking Therapy for the Treatment of Obesity MultiVu

ReShape Lifesciences® Regains Compliance with Nasdaq Minimum Stockholders Equity Requirement - GlobeNewswire

ReShape Lifesciences® Regains Compliance with Nasdaq Minimum Stockholders Equity Requirement GlobeNewswire

ReShape Lifesciences® Announces Pricing of $2.6 Million Public Offering - GlobeNewswire

ReShape Lifesciences® Announces Pricing of $2.6 Million Public Offering GlobeNewswire

Neurostimulation: 7 ways it could make our lives better - Medical Design & Outsourcing

Neurostimulation: 7 ways it could make our lives better Medical Design & Outsourcing

ReShape Lifesciences Announces 1-for-25 Reverse Stock Split - GlobeNewswire

ReShape Lifesciences Announces 1-for-25 Reverse Stock Split GlobeNewswire

ReShape Lifesciences® Receives Health Canada Approval for its Next-Generation Lap-Band® 2.0 FLEX - GlobeNewswire

ReShape Lifesciences® Receives Health Canada Approval for its Next-Generation Lap-Band® 2.0 FLEX GlobeNewswire

ReShape Lifesciences® Signs Exclusive Distribution Agreement with Recon Supply to Access the VA and DoD Markets - GlobeNewswire

ReShape Lifesciences® Signs Exclusive Distribution Agreement with Recon Supply to Access the VA and DoD Markets GlobeNewswire

ReShape Lifesciences® to Host Special Meeting of Stockholders on July 24, 2025 - GlobeNewswire

ReShape Lifesciences® to Host Special Meeting of Stockholders on July 24, 2025 GlobeNewswire

ReShape Lifesciences® Granted Key International Patent in - GlobeNewswire

ReShape Lifesciences® Granted Key International Patent in GlobeNewswire

ReShape Lifesciences® Announces Strategic Cost Reductions and Provides Update on the Merger Agreement with Vyome Therapeutics and Asset Purchase Agreement with Biorad Medisys - GlobeNewswire

ReShape Lifesciences® Announces Strategic Cost Reductions and Provides Update on the Merger Agreement with Vyome Therapeutics and Asset Purchase Agreement with Biorad Medisys GlobeNewswire

ReShape Lifesciences® Announces Pricing of Upsized $6.0 Million Public Offering - GlobeNewswire

ReShape Lifesciences® Announces Pricing of Upsized $6.0 Million Public Offering GlobeNewswire

ReShape Lifesciences® Receives Notice of Allowance for - GlobeNewswire

ReShape Lifesciences® Receives Notice of Allowance for GlobeNewswire

ReShape Lifesciences® Provides Update on Merger Agreement - GlobeNewswire

ReShape Lifesciences® Provides Update on Merger Agreement GlobeNewswire

ReShape Lifesciences® Receives NIH Supplementary Grant with - GlobeNewswire

ReShape Lifesciences® Receives NIH Supplementary Grant with GlobeNewswire

ReShape Lifesciences® Enters Into Merger Agreement With - GlobeNewswire

ReShape Lifesciences® Enters Into Merger Agreement With GlobeNewswire

Top Enteromedics Employees

Free Chrome Extension

Find emails, phones & company data instantly

Find verified emails from LinkedIn profiles
Get direct phone numbers & mobile contacts
Access company data & employee information
Works directly on LinkedIn - no copy/paste needed
Get Chrome Extension - Free

Aero Online

Your AI prospecting assistant